Advertisement

Advertisement

2018 ASH Annual Meeting

Advertisement

Advertisement



Jan
26
Today In Oncology
Addition of Olaparib to Bevacizumab Maintenance in Patients With Advanced Ovarian Cancer Responding to First-Line Therapy
Everolimus/Octreotide Shows Antitumor Activity in Recurrent Meningioma
Higher Concentration of Fusobacterium nucleatum Found in Colorectal Tumors in Patients Younger Than 45
Cancer Incidence in General WTC Responders to the September 11 Attacks
Price Transparency and Variation for Prostate Cancer Radiation Therapy
View More 
Advertisement
Most Read Stories
'Oral Cryotherapy' for Patients Undergoing Oxaliplatin-Based Chemotherapy
Brentuximab Vedotin Plus Nivolumab in Hodgkin Lymphoma
Tucatinib Combination Extends Survival in HER2-Positive Metastatic Breast Cancer, Including Patients With Brain Metastases
Residual Cancer Burden Is Prognostic of Outcomes Across Breast Cancer Subtypes
When Can Patients With Gleason 6 Prostate Cancer Safely Undergo Active Surveillance?
View More 
Most Viewed Videos
Rashmi K. Murthy, MD, on HER2-Positive Metastatic Breast Cancer: HER2CLIMB Trial of Tucatinib, Capecitabine, and Trastuzumab
Jeffrey A. Meyerhardt, MD, MPH, on Colon Cancer: Results From the ACTS-CC 02 Trial on Adjuvant Chemotherapy
Rowan T. Chlebowski, MD, PhD, on Diet and Breast Cancer: Trial Results
Ivana Sestak, PhD, on Clinical Treatment Score From TAILORx: Predicting Distant Breast Cancer Recurrence
Luca Gianni, MD, on the Neoadjuvant Treatment of Triple-Negative Breast Cancer
View More 
© 2020 HSP News Service, L.L.C.